Public Health
Volume 121, Issue 1 , Pages 45-50 , January 2007

How has legislation restricting paracetamol pack size affected patterns of deprivation related inequalities in self-harm in Scotland?

  • D.R. Gorman

      Affiliations

    • NHS Lothian, 148 The Pleasance, Edinburgh, EH8 9RS, Scotland, UK
    • Corresponding Author InformationCorresponding author. Tel.: +1315369165; fax: +1315369164.
  • ,
  • M. Bain

      Affiliations

    • NHS Scotland, Information and Statistics Division, Gyle Square, 1 South Gyle Crescent, Edinburgh, EH12 9EB, UK
  • ,
  • J.H.C. Inglis

      Affiliations

    • NHS Health Scotland, Woodburn House, Canaan Lane, Edinburgh EH10 4SG, UK
  • ,
  • D. Murphy

      Affiliations

    • NHS Scotland, Information and Statistics Division, Gyle Square, 1 South Gyle Crescent, Edinburgh, EH12 9EB, UK
  • ,
  • D.N. Bateman

      Affiliations

    • Scottish Poisons Information Bureau, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK

Received 25 March 2005 ,Revised 17 July 2006 ,Accepted 24 August 2006.

References 

  1. Inglis JHC. Restricting sales of paracetamol tablets: effect on deaths and emergency admissions for poisoning in Scotland 1991–2002. SMJ. 2004;49:142–143
  2. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, MacDonald TM. Poisoning with paracetamol, ibuprofen and aspirin. How much is due to prescribed medication. J R Coll Physicians Edinb. 2003;33:258–261
  3. Bateman DN, Bain M, Gorman D, Murphy D. Changes in paracetamol, antidepressants and opioid poisoning in Scotland during the 1990s. Q J Med. 2003;96:125–132
  4. Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ. 2004;329:1076–1080
  5. Hawton K, Townsend E, Deeks J, Appleby L, Gunnell D, Bennewith O, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ. 2001;322:1203–1207
  6. Turvill JL, Burroughs AK, Moore KP. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet. 2000;355:2048–2049
  7. Robinson D, Smith AMJ, Johnson GD. Severity of overdose after restriction of paracetamol availability: retrospective study. BMJ. 2000;321:926–927
  8. Prince MI, Thomas SHL, James ONW, Hudson M. Reduction in incidence of severe paracetamol poisoning. Lancet. 2000;355:2047–2048
  9. Morgan O, Griffiths C, Majeed A. impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study. J Public Health. 2005;27:19–24
  10. Bateman DN, Gorman DR, Bain M, Inglis JHC, House FR, Murphy D. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br J Clin Pharmacol (in press) Available online www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2006.02668.x;jsessionid=efJMpVgDTlY_Z0ho7V (last accessed 24 August 2006).
  11. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, MacDonald TM. Paracetamol related deaths in Scotland, 1994–2000. Br J Clin Pharmacol. 2002;54:430–432
  12. Newsome PN, Bathgate AJ, Henderson NL, MacGilchrist AJ, Plevris JN, Masterton G, et al. Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland. Lancet. 2001;358:1612–1613
  13. McLoone P. Carstairs scores for Scottish postcode sectors from the 1991 census. Glasgow: Public Health Research Unit; 2001;
  14. Deary IJ, Hart CL. Intelligence in childhood and health in later life. Chief Scientists Office Newsetter 2003;Issue 23:9.
  15. Glouberman S, Millar J. Evolution of the determinant of health policy and health information systems in Canada. Am J Public Health. 2003;93:388–393
  16. Platt S. Tackling suicide in Scotland: a national strategy and action plan. J Mental Health Promot. 2003;2:40–48
  17. Scottish Executive. Choose life a national strategy and action plan to prevent suicide in Scotland. Edinburgh: The Stationary Office; 2002;
  18. Co-proxamol to be withdrawn from the market. Available at http://www.mhra.gov.uk/news/january/co-proxamol_healthprofessional.pdf (last accessed 10 February 2005)

PII: S0033-3506(06)00255-1

doi: 10.1016/j.puhe.2006.08.014

Public Health
Volume 121, Issue 1 , Pages 45-50 , January 2007